These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14204592)

  • 21. [Intervention of heparin in immunological phenomena: reversibility of the nuclear antigen and antinuclear antibody reaction in systemic lupus erythematosus].
    Bardare M; Menghi P
    Boll Soc Ital Biol Sper; 1965 Jul; 41(13):713-5. PubMed ID: 4164914
    [No Abstract]   [Full Text] [Related]  

  • 22. Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus.
    Chen M; Zhao MH; Zhang Y; Wang H
    Lupus; 2004; 13(8):584-9. PubMed ID: 15462487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic aspects of lupus erythematosus cells and antinuclear factors in disease states.
    Barnett EV
    Mayo Clin Proc; 1969 Sep; 44(9):645-8. PubMed ID: 4186061
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic lupus erythematosus.
    Koffler D
    Sci Am; 1980 Jul; 243(1):40-9. PubMed ID: 6450445
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunological studies in patients with discoid lupus erythematosus.
    Husz S; Szabó E; Berkò G; Hunyadi J; Dobozy A; Simon N
    Diagn Histopathol; 1981; 4(2):149-55. PubMed ID: 7021113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Auto antibodies to nucleosides in systemic lupus erythematosus.
    Chablani AT; Badakere SS; Bhatia HM
    Indian J Med Res; 1990 Jun; 92():151-7. PubMed ID: 1698174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Milk fat globule-EGF factor 8 suppresses the aberrant immune response of systemic lupus erythematosus-derived neutrophils and associated tissue damage.
    Huang W; Wu J; Yang H; Xiong Y; Jiang R; Cui T; Ye D
    Cell Death Differ; 2017 Feb; 24(2):263-275. PubMed ID: 27768123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus.
    Eriksson C; Rantapää-Dahlqvist S
    Lupus; 2014 Jun; 23(7):691-6. PubMed ID: 24531079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Systemic lupus erythematosus, the significance of immunologic tests].
    Michelsen B
    Z Hautkr; 1986 May; 61(10):667-70. PubMed ID: 2424185
    [No Abstract]   [Full Text] [Related]  

  • 30. Antinuclear factors, rheumatoid factors and Bordet-Wassermann reaction in chronic and systemic lupus erythematosus.
    Strejcek J; Malina L; Bielický T
    Acta Derm Venereol; 1968; 48(3):198-202. PubMed ID: 4176741
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antinuclear factors].
    Zitnan D
    Beitr Rheumatol; 1967; 12():163-94. PubMed ID: 4179770
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunologic aberrations in the Di Guglielmo syndrome.
    Finkel HE; Brauer MJ; Taub RN; Dameshek W
    Blood; 1966 Nov; 28(5):634-49. PubMed ID: 4162466
    [No Abstract]   [Full Text] [Related]  

  • 33. [Loss of T-lymphocytes with suppressor function in patients with systemic lupus erythematosus (SLE)].
    Manke HG
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():839-40. PubMed ID: 306175
    [No Abstract]   [Full Text] [Related]  

  • 34. [Problems of immuno-gerontology: research on anti-nuclear antibodies in old age].
    Ghigliotti G; Azzena D; Azzolini A; Battaglia A
    Acta Gerontol (Milano); 1967; 17(4):202-11. PubMed ID: 4179189
    [No Abstract]   [Full Text] [Related]  

  • 35. PASSIVE TRANSFER OF ANTINUCLEAR ACTIVITY IN IMMUNOLOGICALLY TOLERANT ANIMALS.
    CLARK RF; BURKHART CR; BATES HR
    Arthritis Rheum; 1963 Oct; 6():573-80. PubMed ID: 14066080
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lupus erythematosus].
    Goerz G; Lehmann P; Schuppe HC; Lakomek HJ; Kind P
    Z Hautkr; 1990 Mar; 65(3):226, 229-34. PubMed ID: 2339576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laboratory diagnosis in systemic erythematodes. 2. So-called Sjögren's cell a variation of LE cell].
    Bauer R; Schütz R
    Z Hautkr; 1978 Mar; 53(6):173-9. PubMed ID: 77591
    [No Abstract]   [Full Text] [Related]  

  • 38. [DEMONSTRATION OF THE LE FACTOR BY THE IMMUNOFLUORESCENT METHOD].
    KRAMAR J; STREJCEK J; REJHOLEC V
    Cas Lek Cesk; 1964 Mar; 103():255-8. PubMed ID: 14138932
    [No Abstract]   [Full Text] [Related]  

  • 39. [Antinuclear factor, phenomena of the LE cells and complement in systemic erythematosus].
    Okuda M
    Nihon Rinsho; 1968 Dec; 26(12):3438-48. PubMed ID: 4181083
    [No Abstract]   [Full Text] [Related]  

  • 40. [Molecular targets and their regulation in systemic lupus erythematosus and lupus nephritis].
    Takasaki Y
    Nihon Jinzo Gakkai Shi; 2012; 54(5):598-602. PubMed ID: 22991839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.